NEW DELHI: CoSara Diagnostics Pvt Ltd, the first Indian company to get a licence to produce Covid-19 testing kits from both Indian and US drug regulators, is ready to supply as many as 10,000 such diagnostic kits a day from the first week of April, director Mohal Sarabhai said. “But before that I will also have 15,000 tests available for the market," Sarabhai said in an interview, adding that the company will also have an additional 5,000 tests imported from the US using its import licence.
CoSara Diagnostics is an Ahmedabad-based joint venture of US-based Co-Diagnostics Inc. and Sarabhai Group. The supply of CoSara Diagnostics’ RT-PCR Covid-19 test kit, which was designed by Co-Diagnostics and would be manufactured in India by the JV